Last reviewed · How we verify
NCT05165979
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil
trial testing Hospitalization due to COVID-19 in COVID-19 in 650 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Hospital Moinhos de Vento |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 650 |
| Start date | 21 December 2021 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 July 2024 |
| Sites | 24 locations across Brazil |
Drugs / interventions tested
- Hospitalization due to COVID-19
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Quality of Life — all drugs for Quality of Life →
- Disability Physical — all drugs for Disability Physical →
- Disabilities Mental — all drugs for Disabilities Mental →
Sponsor
Hospital Moinhos de Vento
Who can join
18 and older, any sex, with COVID-19 or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult survivors of hospitalization for COVID-19. Adult patients requiring hospitalization due to COVID-19 disease will be followed through structured and centralized telephone interviews performed at 3, 6, 9 and 12 months after enrollment.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Long-term Health-Related Quality of Life and Outcomes after Hospitalization for COVID-19 in Brazil: Post-COVID Brazil 1 Study Protocol.
Trott G, Scolari FL, Rover MM, Silva MMDD, et al · · 2023 · cited 3× · PMID 37991122 · DOI 10.36660/abc.20230378 -
One-Year Quality of Life Among Survivors of Hospitalization for Omicron Infection in Brazil: A Multicentre Prospective Cohort Study.
Trott G, Rover MM, Scolari FL, da Silva MMD, et al · · 2025 · PMID 41251137 · DOI 10.1002/jmv.70687 -
Impact of long COVID phenotypes on quality of life following symptomatic omicron infection in Brazil: a machine learning analysis.
Scolari FL, Spinardi J, Silva MMDD, Trott G, et al · · 2025 · PMID 41204118 · DOI 10.1186/s12879-025-11956-6
Verify or expand the search:
- PubMed search for NCT05165979
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Hospital Moinhos de Vento trials
Trials by the same sponsor.
- NCT07186517 — Genetic Variants in Stroke · not yet recruiting
- NCT05996861 — Protocol For Sleep for Critically Ill Patients · unknown
- NCT05306600 — Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System · recruiting
- NCT05572736 — Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure · NA · completed
- NCT06903260 — Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study) · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05165979 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Moinhos de Vento
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05165979.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing